Regional Oncology Research Center (American Eurasian Cancer Alliance Supplement)
Regional Oncology Research Center (American Eurasian Cancer Alliance Supplement)
批准号:
10923392
负责人:
WILLIAM George NELSON
金额:
$48.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-01 至 2027-05-31
关键词:
AccelerationAmericanAreaArmeniaAsianAzerbaijanBelarusCOVID-19 pandemicCentral AsiaCountryDevelopmentEducationEstoniaEuropeEuropeanFinancial HardshipGovernmentHealthHuman ResourcesKazakhstanKyrgyzstanLatviaLithuaniaMalignant NeoplasmsMoldovaNCI-Designated Cancer CenterOncologyPoliciesPopulationPreventionPrevention strategyPublic HealthResearchResearch InstituteResearch TrainingResource AllocationResourcesScientistTajikistanTraining and EducationTranslatingUkraineUnited StatesUzbekistanWorkanticancer researchcancer preventioncatalystinterestprogramssuccesstreatment strategyvirtual
中文摘要
项目摘要/摘要
美国欧亚癌症联盟(AECA)成立于2001年,最初名为美俄癌症
联盟(ARCA),代表着来自俄罗斯联邦和
美国。基于ARCA的成功和东欧和中亚日益增长的兴趣
在各国,联盟的范围和深度扩大到欧亚区域,包括研究,
研究培训、从研究到政策,以及卫生外交活动。
该项目于2014年更名为美国欧亚癌症联盟(AECA),以代表
更广泛的国家参与,包括以下区域:俄罗斯联邦、中央
亚洲(哈萨克斯坦、乌兹别克斯坦、吉尔吉斯斯坦、塔吉克斯坦)、中欧(乌克兰、摩尔多瓦、白俄罗斯)、波罗的海国家
(立陶宛、拉脱维亚、爱沙尼亚)和高加索(亚美尼亚、格鲁吉亚、阿塞拜疆)。该联盟的目标是汇集知识分子
和科学资源,以进一步研究和发现癌症预防和治疗策略。AECA‘s
这些计划主要集中在三个领域:
1.加强全球癌症研究
2.推动科研培训和教育
3.将研究转化为政策和计划
AECA与欧亚大陆的几个国家建立了伙伴关系,这些伙伴关系是通过#年的备忘录正式确立的。
卫生部之间在癌症研究、预防和控制方面的合作谅解。穿过
AECA继续与高级别利益攸关方接触,促进欧亚地区的资源分配
政府和癌症研究机构为美国和当地人民的共同利益。这
参与减少了NCI指定的癌症中心和其他美国总部的财务负担
研究所建立和实施他们的研究方案。在COVID大流行期间,AECA继续
它不间断地工作,尽管是通过虚拟渠道,继续促进研究、开展
教育和公共卫生倡议。AECA与NCI人员一起努力进行这项工作。
英文摘要
Project Summary/Abstract
The American Eurasian Cancer Alliance (AECA) was formed in 2001, originally called American Russian Cancer
Alliance (ARCA), representing a unique partnership of scientists and clinicians from Russian Federation and the
United States. Based on the successes of ARCA and growing interest from Eastern European and Central Asian
countries, the scope and depth of the alliance expanded to the Eurasian region encompassing research,
research training, research to policy, and health diplomacy activities.
The program was re-branded under the American Eurasian Cancer Alliance (AECA) in 2014 to represent the
wider range of national participation, which encompasses the following regions: Russian Federation, Central
Asia (Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan), Central Europe (Ukraine, Moldova, Belarus), Baltics
(Lithuania, Latvia, Estonia), and Caucasus (Armenia, Georgia, Azerbaijan). The Alliance aims to pool intellectual
and scientific resources to further research and discovery in cancer prevention and treatment strategies. AECA’s
programs focus on three main areas:
1. Strengthening Global Cancer Research
2. Promoting Research Training and Education
3. Translating Research into Policy and Programs
AECA has formed partnerships with several countries in Eurasia which were formalized through Memoranda of
Understanding between Ministries of Health for cooperation in cancer research, prevention, and control. Through
continued engagement with high-level stakeholders, AECA facilitates allocation of resources by Eurasian
governments and cancer research institutes for the mutual benefit of U.S. and local populations. This
engagement results in reduced financial burden to NCI-Designated Cancer Centers, and other U.S.-based
institutes to establish and implement their research programs. During the COVID pandemic, AECA has continued
its worked uninterrupted, albeit through virtual channels, by continuing to facilitate research, conducting
education and public health initiatives. AECA works with NCI personnel in this effort.
期刊论文(771)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1007/s10549-020-05910-0
发表时间:
2020-12
期刊:
Breast cancer research and treatment
影响因子:
3.8
作者:
[Lee KT, Jacobs L, Walsh EM, Stearns V, Segal JB]
通讯作者:
Segal JB
DOI:
10.1172/jci164420
发表时间:
2022-11-15
期刊:
JOURNAL OF CLINICAL INVESTIGATION
影响因子:
15.9
作者:
[Hall, Connor P., Cronk, James C., Rubens, Jeffrey A.]
通讯作者:
Rubens, Jeffrey A.
DOI:
10.1038/s41568-022-00473-2
发表时间:
2022-08
期刊:
Nature reviews. Cancer
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1002/cncr.34190
发表时间:
2022-06-15
期刊:
Cancer
影响因子:
6.2
作者:
[]
通讯作者:
DOI:
10.1002/ijc.31885
发表时间:
2019-05-15
期刊:
International journal of cancer
影响因子:
6.4
作者:
[Tsang SH, Peisch SF, Rowan B, Markt SC, Gonzalez-Feliciano AG, Sutcliffe S, Platz EA, Mucci LA, Ebot EM]
通讯作者:
Ebot EM
共 436 条
Regional Oncology Research Center (LLMs for Unstructured Data Extraction)
-
批准号:10891024
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2023
-
负责人:WILLIAM George NELSON
-
依托单位:
Regional Oncology Research Center
-
批准号:10409122
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2021
-
负责人:WILLIAM George NELSON
-
依托单位:
SENIOR LEADERSHIP
-
批准号:8710423
-
项目类别:
-
资助金额:$4.38万
-
财政年份:2013
-
负责人:WILLIAM George NELSON
-
依托单位:
SENIOR LEADERSHIP
-
批准号:8723547
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2013
-
负责人:WILLIAM George NELSON
-
依托单位:
Screen for Small Molecule Antagonists of MBD2
-
批准号:8519572
-
项目类别:
-
资助金额:$3.93万
-
财政年份:2012
-
负责人:WILLIAM George NELSON
-
依托单位:
Screen for Small Molecule Antagonists of MBD2
-
批准号:8409737
-
项目类别:
-
资助金额:$4.05万
-
财政年份:2012
-
负责人:WILLIAM George NELSON
-
依托单位:
MBD2 as a Target for Cancer Prevention and Treatment
-
批准号:7070564
-
项目类别:
-
资助金额:$28.37万
-
财政年份:2005
-
负责人:WILLIAM George NELSON
-
依托单位:
MBD2 as a Target for Cancer Prevention and Treatment
-
批准号:6899546
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2005
-
负责人:WILLIAM George NELSON
-
依托单位:
MBD2 as a Target for Cancer Prevention and Treatment
-
批准号:7245006
-
项目类别:
-
资助金额:$30.7万
-
财政年份:2005
-
负责人:WILLIAM George NELSON
-
依托单位:
AUA/SBUR Res. Conf.-"Inflammation in Prostate Diseases"
-
批准号:7001935
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2005
-
负责人:WILLIAM George NELSON
-
依托单位:
PROSTATIC TOPOISOMERASES AS THERAPEUTIC DRUG TARGETS
-
批准号:6600893
-
项目类别:
-
资助金额:$13.16万
-
财政年份:2002
-
负责人:WILLIAM George NELSON
-
依托单位:
RATIONAL PROSTATE CANCER PREVENTION USING GST INDUCERS
-
批准号:6600895
-
项目类别:
-
资助金额:$13.16万
-
财政年份:2002
-
负责人:WILLIAM George NELSON
-
依托单位:
RATIONAL PROSTATE CANCER PREVENTION USING GST INDUCERS
-
批准号:6660489
-
项目类别:
-
资助金额:$13.16万
-
财政年份:2002
-
负责人:WILLIAM George NELSON
-
依托单位:
PROSTATIC TOPOISOMERASES AS THERAPEUTIC DRUG TARGETS
-
批准号:6660487
-
项目类别:
-
资助金额:$13.16万
-
财政年份:2002
-
负责人:WILLIAM George NELSON
-
依托单位:
Howard/Hopkins Cancer Centers Partnership
-
批准号:7500248
-
项目类别:
-
资助金额:$100.06万
-
财政年份:2001
-
负责人:WILLIAM George NELSON
-
依托单位:
Howard/Hopkins Cancer Centers Partnership
-
批准号:7685503
-
项目类别:
-
资助金额:$97.61万
-
财政年份:2001
-
负责人:WILLIAM George NELSON
-
依托单位:
Howard/Hopkins Cancer Centers Partnership
-
批准号:7939601
-
项目类别:
-
资助金额:$98.65万
-
财政年份:2001
-
负责人:WILLIAM George NELSON
-
依托单位:
RATIONAL PROSTATE CANCER PREVENTION USING GST INDUCERS
-
批准号:6346030
-
项目类别:
-
资助金额:$13.16万
-
财政年份:2000
-
负责人:WILLIAM George NELSON
-
依托单位:
PROSTATIC TOPOISOMERASES AS THERAPEUTIC DRUG TARGETS
-
批准号:6347352
-
项目类别:
-
资助金额:$13.16万
-
财政年份:2000
-
负责人:WILLIAM George NELSON
-
依托单位:
PROSTATIC TOPOISOMERASES AS THERAPEUTIC DRUG TARGETS
-
批准号:6494753
-
项目类别:
-
资助金额:$13.16万
-
财政年份:2000
-
负责人:WILLIAM George NELSON
-
依托单位:
海外基金